Food & Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food & Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agile Therapeutics
Contraceptive patch maker closes $4.5M financing
September 24th, 2004
Agile Therapeutics, a pharmaceutical development company, announced the completion of a new round of financing bringing to $20 million the total capital raised-to-date. Based on their high level of confidence in the company's leadership and the promise of its lead product, a second-generation transdermal contraceptive, The Hillman Company, TL Ventures and PA Early Stage Partners, participated to the full extent of their rights. "Agile Therapeutics has a strong opportunity to bring an exciting product into a rapidly growing segment of the women's healthcare market. We at TL are pleased to continue our support for Agile on its path to commercial...
Source: Food & Drug Law Weekly (2004-09-24)
|
